Long Intergenic Non-Coding RNA 00511 (LINC00511) Genetic Variations and Haplotypes in Breast Cancer: A Case-Controlled Study and Bioinformatics Analysis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26199328 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shorouk Eldash und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology and Biochemistry Department, Faculty of Pharmacy, The British University in Egypt (BUE), El-Sherouk, Cairo 11837, Egypt. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Breast Neoplasms, Polymorphism, Single Nucleotide, Haplotypes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Long intergenic non-coding RNA 00511 (LINC00511) has been involved in the development of several types of cancer including breast cancer (BC). Several single nucleotide polymorphisms (SNPs) can be found in the genomic regions of long non-coding RNAs (lncRNAs) and are associated with the tumorigenesis of many cancers. The objective of the current study is to assess whether LINC00511 SNPs (rs11657109, rs9906859, rs17780195, rs1558535, and rs4432291) could be related with BC incidence in the Egyptian population. Five SNPs of LINC00511 were analyzed in a case–control study of 267 BC cases and 150 controls. Logistic regression analysis was used to test the association between LINC00511 SNPs and BC incidence. We found that the TT genotype of rs11657109 significantly increased BC incidence (OR: 2.177, 95%CI: 1.260–3.763) and this SNP was associated with high incidence of luminal A BC specifically using different genetic models. Haplotype (A09 A91 A35 G95 T59) was strongly associated with an increased BC incidence as it was totally absent in controls. These findings suggest that LINC00511 SNP rs11657109 is associated with BC susceptibility in the Egyptian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacology and Biochemistry Department, Faculty of Pharmacy, The British University in Egypt (BUE), El-Sherouk, Cairo 11837, Egypt.
- Health Research Center of Excellence, Drug Research and Development Group, The British University in Egypt (BUE), El-Sherouk, Cairo 11837, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Ain Shams University, Abassia, Cairo 11566, Egypt.
- Clinical and Chemical Pathology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt.
- Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura 35516, Dakahlia, Egypt.
ORCID-Profile: Shorouk Eldash, Eman F Sanad, Reham A A Elshimy, Ahmad A Hady, Nadia M Hamdy
Zitieren
APA
Eldash, S., Sanad, E. F., Elshimy, R. A. A., Hady, A. A., Nada, D., & Hamdy, N. M. (2025). Long Intergenic Non-Coding RNA 00511 (LINC00511) Genetic Variations and Haplotypes in Breast Cancer: A Case-Controlled Study and Bioinformatics Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199328
Vancouver
Eldash S, Sanad EF, Elshimy RAA, Hady AA, Nada D, Hamdy NM. Long Intergenic Non-Coding RNA 00511 (LINC00511) Genetic Variations and Haplotypes in Breast Cancer: A Case-Controlled Study and Bioinformatics Analysis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199328
BibTeX
@article{Eldash2025,
author = {Eldash, Shorouk and Sanad, Eman F and Elshimy, Reham A A and Hady, Ahmad A and Nada, Dina and Hamdy, Nadia M},
title = {Long Intergenic Non-Coding RNA 00511 (LINC00511) Genetic Variations and Haplotypes in Breast Cancer: A Case-Controlled Study and Bioinformatics Analysis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26199328}
}
EUVIMED